Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Master's degree
Bachelor's degree
2024
Takeda Ventures focuses on high-caliber, therapeutic, platform-based opportunities around the world. We invest in preclinical opportunities that complement Takeda’s pipeline and products. Our mission is to create strategic growth opportunities for Takeda by investing in and nurturing innovative, therapeutics companies in areas aligned with Takeda’s R&D foci which include; Oncology, Gastrointestinal, Inflammation and Neuroscience.
2023 - 2024
2021 - 2023
2020 - 2021
2023
2021
2021
Audit Committee
2022
2021
2021
Compensation Committee
2021
2021 - 2022
2021 - 2022
+ Served in a dual role capacity on an interim basis to support Takeda’s GI BD team while Takeda sourced a new team lead. + Managed BD transaction team for preclinical and clinical transactions for TAK’s GI Drug Development and Therapeutic Area Units + Led and guided negotiations of term sheets through to deal structuring for collaborations & licensing + Responsible for advising on strategic transactions and management of existing partnerships
2021 - 2022
2021 - 2022
2016 - 2020
2016 - 2020
Formerly miRagen Therapeutics (NASDAQ:MGEN) + Member of MGEN’s Senior Leadership Team - Advising on corporate and commercial strategy + Head of Legal - Managed internal attorney team and multiple outside counsel internationally - Responsible for all legal and business term negotiations for all operational elements at MGEN - Supported Investor Relations and SEC compliance during and after MGEN’s reverse merger and listing on NASDAQ + Head of Business Development - Lead negotiator for term sheets, deal structuring for collaborations, and licensing - Responsible for strategic partnering, deal diligence, asset valuation, and market assessment - Lead for all partnering outreach across multiple therapeutic areas: oncology, cardiology, neurology, autoimmunity, dermatology, diabetes, fibrosis and ophthalmology